FDA translation requirement

The FDA requires that all labeling and promotional materials for pharmaceuticals, medical devices, and biologics be translated into the languages of the target market. The translations must be accurate, complete, and clearly convey the intended message. The FDA also requires that translations are performed by qualified translators and reviewed by a second qualified person to ensure accuracy. Additionally, the FDA may request translation of clinical trial documents and other regulatory materials.